Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Daclizumab, an IL-2 modulating antibody for treatment of multiple sclerosis.
Association of TIM-1 5383-5397ins/del and TIM-3 -1541C>T polymorphisms with multiple sclerosis in Isfahan population.
The BICAMS Battery for Assessment of Lithuanian-Speaking Multiple Sclerosis Patients: Relationship with Age, Education, Disease Disability, and Duration.
Multiple Sclerosis: Methods and Protocols. Preface.
Fecundity in women with multiple sclerosis: an observational mono-centric study.
Functional and structural cerebral changes in key brain regions after a facilitation programme for episodic future thought in relapsing-remitting multiple sclerosis patients.
Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence.
Pediatric inflammatory diseases. Part I: multiple sclerosis.
Revisiting adult neurogenesis and the role of erythropoietin for neuronal and oligodendroglial differentiation in the hippocampus.
Body Mass Index in Multiple Sclerosis: Associations with CSF Neurotransmitter Metabolite Levels.
Late-onset neuromyelitis optica spectrum disorder in AQP4-seropositivepatients in a Chinese population.
Hippocampal function is compromised in an animal model of multiple sclerosis.
Cardiovascular Dysfunction in Multiple Sclerosis.
Numerical status of CD4(+)CD25(+)FoxP3(+) and CD8(+)CD28(-) regulatory T cells in multiple sclerosis.
Development and validation of an administrative data algorithm to estimate the disease burden and epidemiology of multiple sclerosis in Ontario, Canada.
Evidence of Oxidative Stress in Very Long Chain Fatty Acid - Treated Oligodendrocytes and Potentialization of Ros Production Using Rna Interference Directed Knockdown of Abcd1 and Acox1 Peroxisomal Proteins.
Epidemiological characteristics of acute disseminated encephalomyelitis in Nanchang, China: a retrospective study.
Volumetric MRI data correlate to disease severity in metachromatic leukodystrophy.
Association of serum bilirubin and uric acid levels changes during neuroinflammation in patients with initial and relapsed demyelization attacks.
MRI-based diagnostic biomarkers for early onset pediatric multiple sclerosis.
Dicer and microRNA expression in multiple sclerosis and response to interferon therapy.
MRI phenotypes with high neurodegeneration are associated with peripheral blood B-cell changes.
Bilateral optic neuritis associated with scrub typhus.
Does Physical Activity Change Over 24 Months in Persons With Relapsing-Remitting Multiple Sclerosis?
Autoimmune disease preceding amyotrophic lateral sclerosis: An epidemiologic study.
Pages
« first
‹ previous
…
633
634
635
636
637
638
639
640
641
…
next ›
last »